Profile data is unavailable for this security.
About the company
Nemaura Medical, Inc. is a medical technology company developing and commercializing non-invasive wearable diagnostic devices. The Company is commercializing sugarBEAT and proBEAT. The Company, through its operating subsidiaries, performs medical device research and manufacturing of a continuous glucose monitoring system (CGM), sugarBEAT. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes and also be used to screen pre-diabetic patients. The sugarBEAT device extracts from analytes, such as glucose, from the surface of the skin in a non-invasive manner where it is measured using sensors and interpreted using an algorithm. The SugarBEAT works by extracting glucose from the skin into a chamber in the patch that is in direct contact with an electrode-based sensor. The proBEAT combines non-invasive glucose data processed using artificial intelligence and a digital healthcare subscription service.
- Revenue in USD (TTM)0.00
- Net income in USD-10.65m
- Incorporated2013
- Employees36.00
- LocationNemaura Medical Inc57 W 57th StNEW YORK 10019-2802United StatesUSA
- Phone+44 (150) 922-2912
- Websitehttps://nemauramedical.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SETO Holdings Inc | 4.96m | -652.00k | 1.00m | 18.00 | -- | 0.0911 | -- | 0.2024 | -0.056 | -0.056 | 0.3994 | 0.134 | 1.57 | 2.65 | 8.51 | -- | -20.70 | 3.84 | -29.07 | 5.95 | 52.83 | 52.44 | -13.15 | 3.92 | 0.9921 | 1.24 | 0.304 | 0.00 | 19.01 | 5.44 | -61.23 | -- | -- | -- |
| Remedent Inc | 1.13m | -259.38k | 1.10m | 16.00 | -- | 0.2324 | -- | 0.9743 | -0.013 | -0.013 | 0.0565 | 0.2367 | 0.1474 | 3.45 | 2.69 | -- | -3.24 | 7.35 | -5.20 | 12.93 | 65.38 | 64.60 | -21.97 | 21.20 | 0.2033 | -0.772 | 0.00 | -- | -33.63 | -21.70 | -140.31 | -- | -- | -- |
| Invivo Therapeutics Holdings Corp | 0.00 | -9.33m | 1.15m | 6.00 | -- | 0.1288 | -- | -- | -3.53 | -3.53 | 0.00 | 2.87 | 0.00 | -- | -- | 0.00 | -81.32 | -73.69 | -94.35 | -85.63 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -6.01 | -- | 19.74 | -- |
| Hawkeye Systems Inc | 0.00 | -804.18k | 1.21m | 44.00 | -- | -- | -- | -- | -0.1186 | -0.1186 | 0.00 | -0.29 | 0.00 | -- | -- | -- | -66.07 | -330.11 | -- | -- | -- | -- | -- | -218.49 | -- | -2.78 | 10.45 | -- | -- | -- | 4.85 | -- | -- | -- |
| Kelyniam Global Inc | 517.70k | -420.28k | 1.29m | 0.00 | -- | 2.41 | -- | 2.49 | -0.0253 | -0.0253 | 0.0312 | 0.0179 | 0.4135 | 7.04 | 4.38 | -- | -33.57 | -- | -41.79 | -- | 18.86 | -- | -81.18 | -- | 1.26 | -- | 0.6232 | -- | -26.47 | -- | -19.10 | -- | -- | -- |
| Bone Biologics Corp | 0.00 | -8.95m | 1.48m | 2.00 | -- | 0.3088 | -- | -- | -77.05 | -77.05 | 0.00 | 5.44 | 0.00 | -- | -- | 0.00 | -146.30 | -98.31 | -202.15 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -502.76 | -- | -- | -- |
| Escalon Medical Corp | 12.38m | 450.50k | 1.48m | 38.00 | 7.72 | 1.58 | 2.99 | 0.1198 | 0.0259 | 0.0259 | 1.18 | 0.1951 | 2.65 | 4.04 | 8.01 | 325,898.70 | 14.68 | -1.76 | 35.71 | -3.67 | 46.26 | 44.57 | 5.54 | -0.9114 | 1.09 | 31.90 | 0.1504 | -- | 13.80 | 1.33 | 760.89 | -17.06 | -19.85 | -- |
| Nemaura Medical Inc | 0.00 | -10.65m | 1.54m | 36.00 | -- | -- | -- | -- | -0.3787 | -0.3787 | 0.00 | -0.6169 | 0.00 | 0.00 | -- | 0.00 | -117.49 | -58.18 | -- | -131.96 | -- | -- | -- | -7,384.83 | 0.0305 | -1.47 | 10.81 | -- | -84.71 | -- | -1.85 | -- | 64.14 | -- |
| Tivic Health Systems Inc | 1.23m | -8.26m | 1.57m | 16.00 | -- | 0.2721 | -- | 1.28 | -42.45 | -42.45 | 2.75 | 3.93 | 0.1613 | 1.07 | 10.86 | 76,687.50 | -108.51 | -- | -135.42 | -- | 26.49 | -- | -672.78 | -- | 5.53 | -- | 0.00 | -- | 46.38 | -- | -18.86 | -- | -- | -- |
| Grapefruit USA Inc | 34.85k | -4.37m | 1.66m | 9.00 | -- | -- | -- | 47.63 | -0.008 | -0.008 | 0.00006 | -0.0101 | 0.0121 | 1.31 | 0.2259 | 3,872.22 | -151.85 | -268.93 | -- | -- | -1,304.65 | -10.09 | -12,531.68 | -408.87 | 0.0388 | -1.50 | -- | -- | -83.96 | 77.87 | -35.68 | -- | -- | -- |
| Prosomnus Inc | 25.61m | -15.02m | 1.74m | 129.00 | -- | -- | -- | 0.0679 | -0.942 | -0.942 | 1.52 | -1.33 | 1.20 | 11.86 | 8.85 | 198,496.50 | -70.44 | -- | -164.95 | -- | 52.38 | -- | -58.65 | -- | 1.38 | -3.15 | 2.57 | -- | 37.79 | -- | -19.54 | -- | -- | -- |
| NanoVibronix Inc | 2.28m | -3.71m | 1.92m | 10.00 | -- | 0.354 | -- | 0.8415 | -2.15 | -2.15 | 1.30 | 1.95 | 0.3637 | 0.3041 | 13.96 | 228,300.00 | -59.13 | -116.16 | -95.36 | -169.36 | 67.32 | 50.47 | -162.55 | -570.47 | 1.53 | -13.97 | 0.00 | -- | 203.59 | 48.33 | 31.88 | -- | -34.02 | -- |
| Nuwellis Inc | 8.86m | -22.63m | 2.02m | 59.00 | -- | 0.2528 | -- | 0.2284 | -13.45 | -13.45 | 4.51 | 0.5651 | 0.5147 | 1.67 | 5.28 | 150,237.30 | -117.35 | -98.07 | -152.04 | -122.48 | 56.22 | 55.22 | -227.99 | -230.51 | 1.96 | -5.06 | 0.00 | -- | 3.76 | 12.14 | -55.78 | -- | 4.61 | -- |
| VirExit Technologies Inc | 0.00 | -1.80m | 2.28m | -- | -- | -- | -- | -- | -0.0932 | -0.113 | 0.00 | -0.0367 | 0.00 | -- | -- | -- | -6,103.43 | -- | -- | -- | -- | -- | -- | -- | -- | -3.66 | -- | -- | -100.00 | -- | 19.08 | -- | -- | -- |
Data as of May 01 2024. Currency figures normalised to Nemaura Medical Inc's reporting currency: US Dollar USD
3.33%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Alyeska Investment Group LPas of 31 Dec 2023 | 845.06k | 2.92% |
| Citadel Securities LLCas of 31 Dec 2023 | 41.69k | 0.14% |
| XTX Markets LLCas of 31 Dec 2023 | 21.33k | 0.07% |
| Two Sigma Securities LLCas of 31 Dec 2023 | 17.40k | 0.06% |
| UBS Securities LLCas of 31 Dec 2023 | 13.93k | 0.05% |
| Tower Research Capital LLCas of 31 Dec 2023 | 11.87k | 0.04% |
| BlackRock Advisors LLCas of 26 Feb 2021 | 5.60k | 0.02% |
| Wells Fargo Clearing Services LLCas of 31 Dec 2023 | 2.05k | 0.01% |
| Wells Fargo Advisors Financial Network LLCas of 31 Dec 2023 | 2.00k | 0.01% |
| Thrivent Trust Co.as of 31 Dec 2023 | 500.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
